Invesco Health Care Fund Class A (GGHCX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
36.32
+0.12 (0.33%)
Jul 3, 2025, 4:00 PM EDT
-9.56%
Fund Assets 1.17B
Expense Ratio 1.06%
Min. Investment $1,000
Turnover 56.00%
Dividend (ttm) 1.84
Dividend Yield 4.78%
Dividend Growth n/a
Payout Frequency n/a
Ex-Dividend Date Dec 16, 2024
Previous Close 36.20
YTD Return 2.40%
1-Year Return -5.02%
5-Year Return 23.84%
52-Week Low 33.82
52-Week High 42.72
Beta (5Y) 0.68
Holdings 76
Inception Date Aug 7, 1989

About GGHCX

Invesco Health Care Fund Class A is an actively managed mutual fund designed to provide long-term capital growth by investing primarily in equity securities of global health care companies. The fund targets firms recognized as industry leaders and innovators, focusing on those with strong management and competitive advantages. By maintaining a portfolio diversified across sub-sectors such as pharmaceuticals, biotechnology, medical equipment, managed health care, and life sciences tools, the fund captures the dynamic growth potential of the health care industry. With over 70 holdings and a weighted average market capitalization in the large-cap range, the fund includes notable positions in companies like Boston Scientific, Eli Lilly, Stryker, and AbbVie. It invests across all market capitalizations and geographic regions, though it is predominantly U.S.-focused, with selective international exposure. By allocating at least 80% of assets to health care-related securities, Invesco Health Care Fund Class A plays a significant role for investors seeking targeted exposure to advancements and growth trends in global health care markets.

Fund Family Invesco
Category Health
Stock Exchange NASDAQ
Ticker Symbol GGHCX
Share Class Class A
Index S&P Composite 1500 Health Care TR

Performance

GGHCX had a total return of -5.02% in the past year, including dividends. Since the fund's inception, the average annual return has been 9.77%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol Share Class Expense Ratio
GGHYX Class Y 0.81%
GTHIX Investor Class 1.06%
GTHCX Class C 1.81%

Top 10 Holdings

47.01% of assets
Name Symbol Weight
Boston Scientific Corporation BSX 9.75%
Eli Lilly and Company LLY 8.15%
Stryker Corporation SYK 4.90%
Cencora, Inc. COR 4.09%
AbbVie Inc. ABBV 4.09%
Abbott Laboratories ABT 3.74%
Vertex Pharmaceuticals Incorporated VRTX 3.60%
Intuitive Surgical, Inc. ISRG 3.42%
Short-Term Investment Trust - Invesco Treasury Portfolio TRPXX 2.80%
UnitedHealth Group Incorporated UNH 2.48%
View More Holdings

Dividend History

Ex-Dividend Amount Pay Date
Dec 16, 2024 $1.8353 Dec 16, 2024
Dec 16, 2021 $9.9297 Dec 16, 2021
Dec 15, 2020 $0.4737 Dec 15, 2020
Dec 13, 2019 $1.4728 Dec 13, 2019
Dec 14, 2018 $2.9024 Dec 14, 2018
Dec 13, 2017 $2.4481 Dec 13, 2017
Full Dividend History